Results 191 to 200 of about 231,845 (277)

B‐Lymphoblastic Leukemia Presenting as Bilateral Ovarian Masses in a 20‐Year‐Old Woman

Clinical Case Reports, Volume 14, Issue 10, October 2026.
ABSTRACT Hematologic malignancies involving the ovaries are rare and may mimic ovarian carcinoma. We report a 20‐year‐old woman who presented with generalized body pain, bilateral ovarian masses, and abdominal adenopathy, initially suspected to have ovarian carcinoma.
Jennifer Cai, David Sin, Marian Varda, Lauren Lewis, James Yeh   +4 more
wiley   +1 more source

Harnessing Terminalia arjuna in Next Generation Phytomedicine: Cutting Edge Nutraceutical Trends Shaping Food and Health

Food Science &Nutrition, Volume 14, Issue 10, October 2026.
This graphical abstract illustrates the complete translational pipeline of Terminalia arjuna in modern phytomedicine and functional food development. It is rich in key bioactive compounds like arjunolic acid, arjungenin, flavonoids, and tannins which serve as the foundation for the plant's versatile medicinal uses and offers broad therapeutic benefits ...
Ishani Banerjee, Fahika Nazeerulla, Manash Kumar Paul, Sujit Kumar Bhutia, Deblina Basu, Subhadip Mukhopadhyay   +5 more
wiley   +1 more source

Persistent Fever and Splenic Abscess-like Lesions: A Diagnostic Trap in a Young Adult. [PDF]

Mediterr J Hematol Infect Dis
Seow CE, Alwi SNA, Jamali NS, Nair SB.
europepmc   +1 more source

SLV‐404, an anti‐RYK antibody–drug conjugate, is effective in Richter transformation patient‐derived xenografts

HemaSphere, Volume 10, Issue 10, October 2026.
Abstract Richter transformation (RT), a highly aggressive lymphoma arising from a preexisting chronic lymphocytic leukemia, represents a major unmet clinical need. Recent data have shown that an antibody–drug conjugate (ADC) targeting the cell‐surface pseudokinase ROR1 is effective in RT patients.
Matilde Micillo, Beatrice Pirajno, Francesco Edoardo Vallone, Victor Navarro‐Tableros, Elisabetta Bolli, Valentina Griggio, Brian J. Lannutti, Katti A. Jessen, Tiziana Vaisitti, Silvia Deaglio   +9 more
wiley   +1 more source

Case Report: Non-traumatic splenic rupture as the first presentation of diffuse large B-cell lymphoma complicated by clinically diagnosed pulmonary aspergillosis supported by metagenomic next-generation sequencing. [PDF]

Front Med (Lausanne)
Zhao Y, Duan J.
europepmc   +1 more source

Simplification of risk stratification for splenic marginal zone lymphoma: a point-based score for practical use.

, 2014
Piris MA, Matutes E, Abraira V, Bello JL, Perez R, Hernandez M, for the Splenic Marginal Zone Lymphoma Study Group, Domingo Domenech E, Caballero D, Rattotti S, Iannitto E, Mollejo M, Montalban C, Guisado Vasco P, Salar A, Carpaneto A, Carbonell F, Ferreri AJ, ARCAINI, LUCA   +18 more
core   +1 more source

Newly diagnosed and relapsed follicular lymphoma: EHA Clinical Practice Guidelines for diagnosis, treatment, and follow‐up

HemaSphere, Volume 10, Issue 10, October 2026.
Abstract Follicular lymphoma (FL) is the second most common lymphoma subtype in Europe, with a median age at diagnosis of 60–65 years. It is generally considered an indolent disease, and the median overall survival at diagnosis now likely exceeds 20 years. However, considerable heterogeneity exists.
Marco Ladetto, Natacha Bolaños, Guy Bouguet, Klaus Herfarth, Wolfram Klapper, Sirpa Leppa, Kim Linton, Armando Lopez‐Guillermo, Stefano Luminari, Franck Morschhauser, Jessica Okosun, Ewa Paszkiewicz‐Kozik, Catherine Thieblemont, Sanne Helene Tonino, Marek Trneny, Judith Trotman, Umut Yilmaz, Martin Dreyling   +17 more
wiley   +1 more source

Real‐World Treatment Patterns, Burden of Illness, and Survival of Autologous Stem Cell Transplant‐Ineligible Patients With Mantle Cell Lymphoma in Ontario, Canada

eJHaem, Volume 7, Issue 5, October 2026.
 . ABSTRACT Introduction Since the approval of ibrutinib in 2016 in Canada for relapsed or refractory (R/R) mantle cell lymphoma (MCL), there has been limited evidence characterizing treatment patterns, burden of illness, and survival in Canadian patients ineligible for autologous stem cell transplant (ASCT).
Sydney George, Soo Jin Seung, Sandra Thibault, Anisia Wong, Mackenzie A. Hamilton, Anca Prica   +5 more
wiley   +1 more source

Modified Newcastle Regimen Improves Survival Despite Central Nervous System Relapse in Monomorphic Epitheliotropic Intestinal T‐Cell Lymphoma

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Background Monomorphic epitheliotropic intestinal T‐cell lymphoma (MEITL) is a rare, aggressive malignancy with a median overall survival (OS) of 7–15 months. The Newcastle regimen, comprising cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), ifosfamide, etoposide, and epirubicin (IVE), and intermediate‐dose methotrexate for ...
Minseung Suh, Hyungwoo Cho, Heounjeong Go, Jin‐Sook Ryu, Shin Kim, Kyoungmin Lee, Eun Jin Chae, Chan‐Sik Park, In Hye Song, Kyung Won Kim, Seok‐Byung Lim, In Ja Park, Chan Wook Kim, Yong Sik Yoon, Jaewon Hyung, Dok Hyun Yoon   +15 more
wiley   +1 more source

Sclerosing angiomatoid nodular transformation of the spleen in an 18-year-old man: a case report. [PDF]

J Surg Case Rep
Yamazaki K, Tsutsumi S, Hamamoto A, Kikuchi H, Kubota S, Akasaka H, Sakamoto Y, Shibata S.   +7 more
europepmc   +1 more source